Search research articles
Contact Us
Filters
Showing results (191-200 of 241) with videos related to
Page
of 25
Sort By:
Cancer Immunology, Immunotherapy : CII
|
July 22, 2008
Chordoma and chondrosarcoma gene profile: implications for immunotherapy
Joseph H Schwab, Patrick J Boland, Narasimhan P Agaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2019
Genomic Profiling Identifies Association of <i>IDH1/IDH2</i> Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
Guo Gord Zhu, Khedoudja Nafa, Narasimhan Agaram, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
November 19, 2016
What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey
Olivier D R van Wulfften Palthe, Stein J Janssen, Jay S Wunder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2019
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Yoshiyuki Suehara, Deepu Alex, Anita Bowman, et al.
Cancer Research Communications
|
March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
Josephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Nature
|
September 26, 2018
Discovery of a periosteal stem cell mediating intramembranous bone formation
Shawon Debnath, Alisha R Yallowitz, Jason McCormick, et al.
Molecular Cancer Therapeutics
|
June 5, 2021
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
Tomohiro Fujiwara, Mohamed A Yakoub, Andrew Chandler, et al.
Cancer
|
August 12, 2003
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
Caroline Laverdiere, E Anders Kolb, Jeffrey G Supko, et al.
Clinical Orthopaedics and Related Research
|
August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
John H Healey, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study
Jay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 241) with videos related to
Sort By:
Page
of 25
Cancer Immunology, Immunotherapy : CII
|
July 22, 2008
Chordoma and chondrosarcoma gene profile: implications for immunotherapy
Joseph H Schwab, Patrick J Boland, Narasimhan P Agaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2019
Genomic Profiling Identifies Association of <i>IDH1/IDH2</i> Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
Guo Gord Zhu, Khedoudja Nafa, Narasimhan Agaram, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
November 19, 2016
What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey
Olivier D R van Wulfften Palthe, Stein J Janssen, Jay S Wunder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2019
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Yoshiyuki Suehara, Deepu Alex, Anita Bowman, et al.
Cancer Research Communications
|
March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
Josephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.
Nature
|
September 26, 2018
Discovery of a periosteal stem cell mediating intramembranous bone formation
Shawon Debnath, Alisha R Yallowitz, Jason McCormick, et al.
Molecular Cancer Therapeutics
|
June 5, 2021
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
Tomohiro Fujiwara, Mohamed A Yakoub, Andrew Chandler, et al.
Cancer
|
August 12, 2003
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
Caroline Laverdiere, E Anders Kolb, Jeffrey G Supko, et al.
Clinical Orthopaedics and Related Research
|
August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
John H Healey, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study
Jay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Page
of 25